logo BDSP

Base documentaire

  1. Clinical, pathologic, and economic parameters of laparoscopic colon resection for cancer. Discussion. Closing.

    Article, Communication - En anglais

    Southwestern Surgical Congress. Annual meeting. San Antonio, TX, USA, 1998/04/19.


    The appropriateness of laparoscopic colon resection (LCR) as treatment for malignancy has been questioned.


    From 1992 to 1997,91 patients were entered into a prospective study of LCR for cancer.

    Clinical, pathologic, and economic parameters of LCR were compared in a cohort of patients matched for age, tumor stage, and type of colectomy who underwent open colon resection (OCR) during the same time period.


    With a median follow-up of 26 months, there were no significant differences in survival rate for patients in the LCR, converted colon resection, and OCR groups.

    There were no portsite recurrences and the number of lymph nodes harvested was similar among the procedures.

    Hospital stay was significantly shorter if laparoscopic resection was successful.

    Total hospital costs were similar for LCR and OCR ; however, the costs were significantly higher for converted colon resection.


    LCR is a sound oncologic procedure that can be performed with costs similar to OCR.

    Mots-clés Pascal : Carcinome, Côlon, Traitement, Résection chirurgicale, Laparoscopie, Chirurgie endoscopique, Technique, Lymphadénectomie, Pronostic, Epidémiologie, Incidence, Récidive, Homme, Etude longitudinale, Analyse avantage coût, Tumeur maligne, Appareil digestif pathologie, Intestin pathologie, Côlon pathologie, Chirurgie

    Mots-clés Pascal anglais : Carcinoma, Colon, Treatment, Surgical resection, Laparoscopy, Endoscopic surgery, Technique, Lymphadenectomy, Prognosis, Epidemiology, Incidence, Relapse, Human, Follow up study, Cost benefit analysis, Malignant tumor, Digestive diseases, Intestinal disease, Colonic disease, Surgery

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 99-0130542

    Code Inist : 002B25G02. Création : 16/11/1999.